Detalhe da pesquisa
1.
Synthetic biology approaches for enhancing safety and specificity of CAR-T cell therapies for solid cancers.
Cytotherapy
; 2024 Mar 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38639669
2.
Investigation of product-derived lymphoma following infusion of piggyBac-modified CD19 chimeric antigen receptor T cells.
Blood
; 138(16): 1391-1405, 2021 10 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-33974080
3.
Early Stage Professionals Committee proceedings from the International Society for Cell & Gene Therapy 2022 Annual Meeting.
Cytotherapy
; 25(6): 590-597, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36906481
4.
Combining CD34+ stem cell selection with prophylactic pathogen and leukemia directed T-cell immunotherapy to simultaneously reduce graft versus host disease, infection, and leukemia recurrence after allogeneic stem cell transplant.
Am J Hematol
; 98(1): 159-165, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35560045
5.
Successful treatment of CMV, EBV, and adenovirus tissue infection following HLA-mismatched allogeneic stem cell transplant using infusion of third-party T cells from multiple donors in addition to antivirals, rituximab, and surgery.
Transpl Infect Dis
; 23(2): e13528, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33236399
6.
Adoptive cell therapies for posttransplant infections.
Curr Opin Oncol
; 31(6): 574-590, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31593976
7.
Anncaliia algerae Microsporidial Myositis, New South Wales, Australia.
Emerg Infect Dis
; 24(8): 1528-1531, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30014835
8.
Development of CAR T-cell lymphoma in 2 of 10 patients effectively treated with piggyBac-modified CD19 CAR T cells.
Blood
; 138(16): 1504-1509, 2021 10 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-34010392
9.
Cellular therapy for multiple pathogen infections after hematopoietic stem cell transplant.
Cytotherapy
; 19(11): 1284-1301, 2017 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28927824
10.
Characterizing piggyBat-a transposase for genetic modification of T cells.
Mol Ther Methods Clin Dev
; 25: 250-263, 2022 Jun 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35474955
11.
Third-party CMV- and EBV-specific T-cells for first viral reactivation after allogeneic stem cell transplant.
Blood Adv
; 6(17): 4949-4966, 2022 09 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-35819448
12.
The association of mobilising regimen on immune reconstitution and survival in myeloma patients treated with bortezomib, cyclophosphamide and dexamethasone induction followed by a melphalan autograft.
Bone Marrow Transplant
; 56(9): 2152-2159, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33911199
13.
Pathogen-Specific T Cells Beyond CMV, EBV and Adenovirus.
Curr Hematol Malig Rep
; 14(4): 247-260, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31228095
14.
Long-term control of recurrent or refractory viral infections after allogeneic HSCT with third-party virus-specific T cells.
Blood Adv
; 1(24): 2193-2205, 2017 Nov 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-29296867